Y. Truong

Therapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammation.

Jilly F. Evans, D. Lorrain, P. Prasit, 2010, European journal of pharmacology.

Pharmacological Blockade of the DP2 Receptor Inhibits Cigarette Smoke-Induced Inflammation, Mucus Cell Metaplasia, and Epithelial Hyperplasia in the Mouse Lung

Jilly F. Evans, D. Lorrain, P. Prasit, 2010, Journal of Pharmacology and Experimental Therapeutics.

DP2 (CRTh2) Antagonism Reduces Ocular Inflammation Induced by Allergen Challenge and Respiratory Syncytial Virus

Jilly F. Evans, D. Lorrain, P. Prasit, 2011, International Archives of Allergy and Immunology.

Pharmacodynamics, Pharmacokinetics, and Safety of AM211: A Novel and Potent Antagonist of the Prostaglandin D2 Receptor Type 2

K. Holme, C. King, J. Hutchinson, 2012, Journal of clinical pharmacology.

Novel tricyclic antagonists of the prostaglandin D2 receptor DP2 with efficacy in a murine model of allergic rhinitis.

Jilly F. Evans, D. Lorrain, P. Prasit, 2009, Bioorganic & medicinal chemistry letters.

Development of a Synthetic Process towards a Hepatitis C Polymerase Inhibitor

A. Scott, S. Neville, Y. Truong, 2006 .